Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00871195 · ClinicalTrials.gov registry record
A Noninvasive Test for Fetal RHD Genotype
A clinical trial, sponsored by Sequenom.
- Completed
- Registry status
- 520
- Enrollment target
NCT00871195 is a clinical trial that has completed, run by Sequenom. The registered enrollment target is 520 participants.
The verdict
NCT00871195 has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 520 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the performance of Sequenom's noninvasive test for fetal RHD genotype. The test uses MALDI-TOF mass spectrometry to detect DNA. The study is specifically designed to determine whether RHD typing using free fetal DNA in maternal circulation can accurately predict the neonatal RhD phenotype at birth.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 520 participants |
| Start Date | 2009-04 |
| Est. Completion | 2012-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00871195
The ClinicalTrials.gov registry entry for NCT00871195 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 520 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00871195 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00871195 about?
NCT00871195 is a clinical study titled "A Noninvasive Test for Fetal RHD Genotype". The objective of this study is to evaluate the performance of Sequenom's noninvasive test for fetal RHD genotype. The test uses MALDI-TOF mass spectrometry to detect DNA. The study is specifically designed to determine whether RHD typing using free fetal DNA in maternal circulation can accurately pr...
What is the current status of trial NCT00871195?
This trial is currently completed. The enrollment target is 520 participants. The study started on 2009-04. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT00871195?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.